Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
4/11 | 3,120 USD
-2,80% |
-2,80% |
|
Cabaletta Bio Inc |
4/11 | 1,420 USD
0,00% |
0,00% |
|
Calithera Biosciences Inc |
4/11 | 0,000 USD
0,00% |
0,00% |
Cambridge Cognition Holdings plc |
4/11 | 27,500 GBX
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
4/11 | 1,669 USD
+3,02% |
+3,02% |
|
Capricor Therapeutics Inc |
4/11 | 8,920 USD
+8,25% |
+8,25% |
Carbios |
4/11 | 5,100 EUR
-1,35% |
-1,35% |
Cardiol Therapeutics Inc - Class A |
4/11 | 1,440 CAD
-4,00% |
-4,00% |
|
Caredx Inc |
4/11 | 85,860 USD
-2,95% |
-2,95% |
|
Carisma Therapeutics, Inc. |
4/11 | 0,001 USD
+25,00% |
+25,00% |
|
Castle Biosciences Inc |
4/11 | 35,750 USD
+1,74% |
+1,74% |
|
Cel-Sci Corp. |
4/11 | 1,380 USD
-2,13% |
-2,13% |
|
Celldex Therapeutics Inc. |
4/11 | 29,930 USD
+0,74% |
+0,74% |
|
Cellectar Biosciences Inc |
4/11 | 1,230 USD
-6,11% |
-6,11% |
|
Cellectis |
4/11 | 1,170 USD
+7,34% |
+7,34% |
|
Cellectis |
4/11 | 1,028 EUR
-1,25% |
-1,25% |
Celyad Oncology |
11:17 | 0,189 EUR
+3,01% |
+3,01% |
|
Cerus Corp. |
4/11 | 2,415 USD
+3,21% |
+3,21% |
|
Champions Oncology Inc |
4/11 | 4,830 USD
0,00% |
0,00% |
|
Charlottes Web Holdings Inc |
4/11 | 0,315 CAD
+1,61% |
+1,61% |
|
China Pharma Holdings Inc. |
4/11 | 0,588 USD
-3,56% |
-3,56% |
|
China SXT Pharmaceuticals Inc |
4/11 | 2,980 USD
+3,47% |
+3,47% |
|
Cipher Pharmaceuticals Inc |
4/11 | 13,030 CAD
-0,31% |
-0,31% |
|
Citius Pharmaceuticals Inc |
4/11 | 0,551 USD
-3,87% |
-3,87% |
|
Clean Air Metals Inc |
4/11 | 0,055 CAD
+10,00% |
+10,00% |
|
ClearPoint Neuro Inc |
4/11 | 10,160 USD
+4,63% |
+4,63% |
|
Cns Pharmaceuticals Inc |
4/11 | 4,340 USD
-4,62% |
-4,62% |
|
Co-Diagnostics Inc |
4/11 | 0,361 USD
-4,89% |
-4,89% |
|
Cocrystal Pharma Inc |
4/11 | 1,010 USD
-5,61% |
-5,61% |
|
Cogent Biosciences Inc |
4/11 | 31,490 USD
+1,38% |
+1,38% |
|
Coherus Biosciences Inc |
4/11 | 0,850 USD
+5,54% |
+5,54% |
|
Collegium Pharmaceutical Inc |
4/11 | 23,670 USD
-0,25% |
-0,25% |
|
CollPlant Biotechnologies Ltd |
4/11 | 4,230 USD
+2,92% |
+2,92% |
Coloplast |
4/11 | 69,420 EUR
+5,21% |
+5,21% |
|
Compass Pathways Plc |
4/11 | 8,600 USD
+0,12% |
+0,12% |
|
Compass Therapeutics Inc |
4/11 | 0,763 USD
+1,29% |
+1,29% |
|
Compugen Ltd. |
4/11 | 2,030 USD
+1,00% |
+1,00% |
|
Conmed Corp. |
4/11 | 53,660 USD
+13,61% |
+13,61% |
|
Convatec Group |
4/11 | 254,000 GBX
+4,27% |
+4,27% |
|
Cooper Companies, Inc. |
4/11 | 64,420 USD
+5,90% |
+5,90% |
|
Corbus Pharmaceuticals Holdings Inc |
4/11 | 3,570 USD
-7,75% |
-7,75% |
|
Corcept Therapeutics Inc |
4/11 | 79,220 USD
-3,31% |
-3,31% |
|
CorMedix Inc |
4/11 | 5,660 USD
+1,80% |
+1,80% |
|
Corvus Pharmaceuticals Inc |
4/11 | 10,570 USD
+7,53% |
+7,53% |
|
Covalon Technologies Ltd. |
3/11 | 4,370 CAD
-3,74% |
-3,74% |
|
Creo Medical Group Plc |
4/11 | 10,875 GBX
-3,33% |
-3,33% |
|
Crinetics Pharmaceuticals Inc |
31/08 | 84,950 USD
+0,13% |
+0,13% |
|
CRISPR Therapeutics AG |
4/11 | 51,775 USD
+3,57% |
+3,57% |
|
Cronos Group Inc |
4/11 | 3,510 USD
+3,85% |
+3,85% |
|
Crossject |
4/11 | 1,216 EUR
+1,50% |
+1,50% |
|
Cryo-Cell International, Inc. |
4/11 | 5,070 USD
+0,40% |
+0,40% |
|
Cue Biopharma Inc |
4/11 | 19,840 USD
-4,89% |
-4,89% |
|
Cumberland Pharmaceuticals Inc. |
4/11 | 4,440 USD
+3,02% |
+3,02% |
|
CureVac N.V. |
5/01 | 3,892 EUR
+0,36% |
+0,36% |
|
Curis Inc |
4/11 | 1,110 USD
+55,48% |
+55,48% |
|
Currenc Group Inc. |
4/11 | 1,780 USD
-11,44% |
-11,44% |
|
Cyanotech Corp. |
4/11 | 0,450 USD
0,00% |
0,00% |
|
Cyclerion Therapeutics Inc |
8/09 | 3,360 USD
-20,94% |
-20,94% |
|
Cytokinetics Inc |
4/11 | 63,600 USD
+2,07% |
+2,07% |
|
CytomX Therapeutics Inc |
4/11 | 2,350 USD
+7,80% |
+7,80% |
|
Cytosorbents Corp |
4/11 | 4,560 USD
+0,44% |
+0,44% |